Mapping cellular response to destabilized transthyretin reveals cell- and amyloidogenic protein-specific signatures-Reference-Cited by-同舟云学术

Mapping cellular response to destabilized transthyretin reveals cell- and amyloidogenic protein-specific signatures

Published:2023-07-13 Issue:4 Volume:30 Page:379-393
ISSN:1350-6129
Container-title:Amyloid
language:en
Short-container-title:Amyloid

Author:

Ghosh Sabrina¹²,Villacorta-Martin Carlos¹,Lindstrom-Vautrin Jonathan¹,Kenney Devin¹,Golden Carly S.¹,Edwards Camille V.¹²³,Sanchorawala Vaishali²³,Connors Lawreen H.³,Giadone Richard M.¹²,Murphy George J.¹²

Affiliation:

1. Center for Regenerative Medicine, Boston University School of Medicine, Boston, MA, USA

2. Department of Medicine, Section of Hematology and Oncology, Boston University School of Medicine, Boston, MA, USA

3. Amyloidosis Center, Alan and Sandra Gerry Amyloid Research Laboratory, Boston University School of Medicine, Boston, MA, USA

Funder

National Institutes of Health – NIDDK

NCATS

Amyloidosis Foundation and the Young Family Amyloid Research Fund

American Society of Hematology

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13506129.2023.2224494

Reference43 articles.

1. Patient-specific induced pluripotent stem cells for understanding and assessing novel therapeutics for multisystem transthyretin amyloid disease

2. The systemic amyloidoses

3. The Systemic Amyloidoses

4. A library of ATTR amyloidosis patient-specific induced pluripotent stem cells for disease modelling and in vitro testing of novel therapeutics

5. Light-Chain (AL) Amyloidosis: Diagnosis and Treatment

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abnormal global longitudinal strain and reduced serum inflammatory markers in cardiac AL amyloidosis patients without significant amyloid fibril deposition;2024-03-16